REXIPRA FORTE TAB

Specifications
Product Composition: A prescription-strength combined formulation of an antidepressant (selective serotonin reuptake inhibitor) and an anxiolytic (benzodiazepine).
Dosage Strengths:
Escitalopram Oxalate IP equivalent to Escitalopram: 10 mg
Clonazepam IP: 0.5 mg
Physical Form: Film-coated tablets.
Packaging Type: Blister strip packaging.
Storage Conditions: Store protected from moisture, at a temperature not exceeding 25°C. Keep out of the reach of children.
Legal Classification: Schedule H Prescription Drug – Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only. (NRx)
2. General Information
Brand: INTAS
Name: Rexipra Forte (Escitalopram Oxalate and Clonazepam Tablets IP)
Quantity: 15 Tablets per strip.
Type / Form Factor: Pharmaceutical Tablets (Film-coated).
Maximum Shelf Life: 24 months (Manufactured in NOV.2025; Expires in OCT.2027).
Food Preference / FSSAI: Not Applicable. This is a pharmaceutical prescription medication (regulated by the Central Drugs Standard Control Organisation / State Licensing Authority under Mfg. Lic. No.: M/517/09), not a food product or dietary supplement, so it does not carry an FSSAI logo or standard food dietary preference markings.
3. Product Details: Ingredients
Active Ingredients:
Escitalopram Oxalate IP equivalent to Escitalopram: 10 mg
Clonazepam IP: 0.5 mg
Inactive Ingredients (Excipients): Q.S. (Quantum Sufficit / Quantity Sufficient)
Approved Colors Used in Coating:
Ferric Oxide Yellow USP-NF
Titanium Dioxide IP
4. Directions: How to Use
Dosage: As directed by the Physician.
Administration: Typically swallowed whole with water. Do not crush or chew unless specifically advised by your doctor.
Precautions: This medication must strictly be taken under the supervision of a certified medical professional due to its habit-forming potential and clinical nature.
5. Description
Overview: Rexipra Forte is a prescription combination medication used primarily to manage anxiety disorders, panic disorders, and comorbid depression where a rapid relief from acute anxiety symptoms is required alongside long-term mood stabilization.
Visual Elements on Packaging: The back of the aluminum foil strip features clear black text detailing the chemical composition, a distinct red warning band denoting its Schedule H Prescription status, a square matrix QR code for product authentication, and printed manufacturing/expiry details along the bottom edge.
6. Manufacturer Information
Manufactured By: INTAS PHARMACEUTICALS LTD.
Manufacturing Plant Address: Bagheykhola, Majhitar, Sikkim-737 136, INDIA.
Manufacturing License Number: M/517/09
7. Marketed By
Marketed By: INTAS PHARMACEUTICALS LTD.
Corporate Address: Corporate details align with Intas Pharmaceuticals Ltd., a prominent global pharmaceutical company headquartered in India.